Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Bernstein ups Reckitt; Mitchells & Butlers cut

Thu, 28th Jul 2022 09:59

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

BofA cuts GSK price target to 1,815 (1,844) pence - 'neutral'

----------

UBS cuts Rio Tinto price target to 4300 (4400) pence - 'neutral'

----------

Berenberg raises Rio Tinto price target to 4,300 (4,100) pence - 'sell'

----------

Morgan Stanley raises Unilever price target to 3,800 (3,550) pence - 'equal-weight'

----------

Credit Suisse raises Smurfit Kappa price target to 48 (45) EUR - 'outperform'

----------

Morgan Stanley raises Smurfit Kappa target to 4,500 (4,400) p - 'equal-weight'

----------

Morgan Stanley reinitiates Croda with 'overweight' - price target 7,700 pence

----------

JPMorgan reinitiates Flutter with 'overweight' - price target 12,600 pence

----------

Deutsche Bank cuts Aviva price target to 490 (520) pence - 'buy'

----------

Deutsche Bank raises Rightmove target to 610 (600) pence - 'hold'

----------

Citigroup raises British American Tobacco price target to 3,950 (3,900) pence - 'buy'

----------

Bank of America raises Lloyds Banking price target to 60 (57) pence - 'buy'

----------

Berenberg raises Lloyds price target to 55 (52) pence - 'hold'

----------

Goldman Sachs raises Lloyds price target to 61 (59) pence - 'neutral'

----------

RBC raises Lloyds price target to 45 (42) pence - 'underperform'

----------

Bernstein raises Reckitt Benckiser to 'market-perform' (underperform) - price target 6,400 (5,300) pence

----------

Barclays raises Reckitt price target to 9,500 (8,600) pence - 'overweight'

----------

Berenberg raises Reckitt price target to 8,050 (7,375) pence - 'buy'

----------

UBS raises Reckitt price target to 8,700 (8,400) pence - 'buy'

----------

RBC raises Reckitt price target to 7,200 (7,000) pence - 'outperform'

----------

FTSE 250

----------

Credit Suisse raises ITV price target to 118 (116) pence - 'outperform'

----------

Deutsche Bank cuts ITV price target to 90 (100) pence - 'hold'

----------

UBS cuts Ibstock price target to 245 (265) pence - 'buy'

----------

Morgan Stanley cuts Wizz Air price target to 2,600 (2,700) pence - 'equal-weight'

----------

JPMorgan raises Babcock International target to 510 (500) pence - 'overweight'

----------

Berenberg cuts JD Wetherspoon price target to 580 (1,050) pence - 'hold'

----------

Berenberg raises Ibstock price target to 210 (200) pence - 'hold'

----------

Deutsche Bank cuts Mitchells & Butlers target to 230 (270) pence - 'buy'

----------

Berenberg cuts Mitchells & Butlers to 'hold' (buy) - price target 180 (350) pence

----------

Goldman Sachs raises Lancashire price target to 540 (410) pence - 'neutral'

----------

Barclays cuts Wizz Air price target to 3,500 (3,700) pence - 'overweight'

----------

Barclays cuts Provident Financial target to 370 (410) pence - 'overweight'

----------

Barclays raises Primary Health Properties target to 150 (140) pence - 'overweight'

----------

SMALL CAP

----------

Berenberg cuts CVC price target to 2,370 (2,900) pence - 'buy'

----------

Berenberg cuts Restore price target to 500 (570) pence - 'buy'

----------

Morgan Stanley cuts Breedon price target to 104 (108) pence - 'overweight'

----------

Berenberg cuts Anglo Pacific price target to 390 (400) pence - 'buy'

----------

RBC raises Metro Bank price target to 100 (85) pence - 'sector perform'

----------

Deutsche Bank cuts Marston's price target to 50 (60) pence - 'hold'

----------

Berenberg cuts Restaurant Group price target to 65 (110) pence - 'buy'

----------

Berenberg cuts Conduit Holdings price target to 540 (555) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.